(19)
(11) EP 2 227 550 A2

(12)

(88) Date of publication A3:
13.08.2009

(43) Date of publication:
15.09.2010 Bulletin 2010/37

(21) Application number: 08857977.6

(22) Date of filing: 04.12.2008
(51) International Patent Classification (IPC): 
C12N 15/861(2006.01)
(86) International application number:
PCT/EP2008/066762
(87) International publication number:
WO 2009/071613 (11.06.2009 Gazette 2009/24)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 06.12.2007 US 992802 P

(71) Applicant: GlaxoSmithKline Biologicals SA
1330 Rixensart (BE)

(72) Inventors:
  • COHEN, Joseph, D.
    B-1330 Rixensart (BE)
  • MARCHAND, Martine
    B-1330 Rixensart (BE)

(74) Representative: Lonergan, Nerissa Elizabeth et al
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) VACCINE